Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = breast cancer
  • (-) ≠ oncology

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(61 - 80 of 114)

Pages

Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
MDM4 is a rational target for treating breast cancers with mutant p53
Disclosing the Uncertainty Associated with Prognostic Estimates in Breast Cancer: Current Practices and Patients' Perceptions of Uncertainty
Tissue Factor promotes breast cancer stem cell activity in vitro
Morphological and phenotypical features of ovarian metastases in breast cancer patients
Combined evaluation of the FAS cell surface death receptor and CD8+tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2
Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia
SNP-SNP interaction analysis of NF-kappa B signaling pathway on breast cancer survival
Prognostic and predictive value of ER beta 1 and ER beta 2 in the Intergroup Exemestane Study (IES)-first results from PathIES(aEuro)
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Dynamic prediction in breast cancer: proving feasibility in clinical practice using the TEAM trial
Stick Together: A Nordic Walking Group Intervention for Breast Cancer Survivors

Pages